Sagent Pharmaceuticals to be acquired

Sagent Pharmaceuticals Inc. (Nasdaq: SGNT) will be acquired by Nichi-Iko Pharmaceutical for a premium of approximately $736 million in cash. The stock price leaped $6.15 to close at $21.65.



Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.